1981-1983: Research Associate, Department of Pharmacology and Toxicology, Michigan State University, East Lansing, Michigan.

1983-1984: Instructor, Department of Pharmacology and Interdisciplinary Toxicology, University of Arkansas for Medical Sciences (UAMS), Little Rock, Arkansas.

1984-1988: Assistant Professor, Department of Pharmacology and Interdisciplinary Toxicology, UAMS.

1986-1989: Assistant Professor, Department of Anesthesiology, UAMS.

1988-1997: Associate Professor, Department of Pharmacology and Toxicology, UAMS.

1989-present: Associate Professor, Department of Anesthesiology, UAMS.

1995-1997: Vice-president for EPSCoR, Arkansas Science and Technology Authority, Little Rock, Arkansas.

1997-1998: Professor, Department of Pharmacology and Toxicology, UAMS.

1998-present: Professor and Chair, Department of Pharmaceutical Sciences, UAMS.

Richard H. Kennedy, Ph.D., Professor and Chair of the Department of Pharmaceutical Sciences at UAMS, received a B.S. in pharmacy from St. Louis College of Pharmacy in 1975, his Ph.D. from the University of Nebraska Medical Center in 1981 and postdoctoral training in the Department of Pharmacology & Toxicology at Michigan State University between 1981 and 1983.

Dr. Kennedy rose through the academic ranks at UAMS from Instructor to Full Professor in the Department of Pharmacology & Toxicology between 1983 and 1997. From 1995 to 1997 he also served half time as the Vice-president for EPSCoR Research at the Arkansas Science and Technology Authority. In 1998, he assumed the chairmanship of the newly combined Department of Pharmaceutical Sciences at UAMS. He has been the major advisor for eight doctoral students, including one combined M.D., Ph.D. recipient, and has trained three postdoctoral students, five medical students doing research projects, and three clinical fellows.

His research in cardiovascular pharmacology and pathophysiology has resulted in more than 70 peer-reviewed manuscripts and has been funded by a variety of agencies including NIH (both R01's and a Research Career Development Award), the American Heart Association (AHA), the NCAA, the Office of Naval Research (ONR), the U.S. Air Force (USAF) and the EPA. Current support includes an NIAAA-funded project examining gender-associated differences in cardiac tolerance to alcohol, an NIGMS-funded R25 Minority Bridging Award, which is designed to attract M.S. graduates from the University of Arkansas at Pine Bluff, a primarily minority campus in the Delta region of Arkansas, to doctoral programs at UAMS, and an EPA-EPSCoR program designed to enhance toxicology research in Arkansas via enhanced electronic communications and pilot funding. In addition, he is collaborating on NIH-, ONR-, and USAF-funded projects examining the cardiac toxicity of oxidized phospholipids, the insulin-resistance associated with dioxin exposure, and the signaling pathways and cardiac actions of cytokines. Dr. Kennedy serves regularly on various peer-review groups including NIH, the AHA, the VA Merit Program and the British Columbia Health Care Research Foundation. He is currently CO-chair of an AHA/Great America Peer-Review Group focusing on cellular physiology and pharmacology and serves as Chair of the AHA/Heartland Research Committee.